SCG(SH:600170) Sou Hu Cai Jing·2025-09-17 15:11Group 1 - Amperon: Revenue from robotic force sensor products accounts for a very low proportion of the company's main business revenue [1] - Tianpu Co., Ltd.: Stock trading suspension review has been completed, and trading will resume tomorrow [2] - Shanghai Construction Group: Revenue from gold business accounts for a low proportion of the company's total revenue [2] Group 2 - Haon Auto Electric: Products in the robotics business are still in the research and development stage and have not yet generated revenue [6] - Zhonghuan Hailu: Recent operating conditions and internal and external business environments have not undergone significant changes [6] - Yongding Co., Ltd.: Controlling shareholder Yongding Group plans to reduce its stake in the company by no more than 3% [6] Group 3 - Royal Technology: Controlling shareholder and actual controller Ma Rongfen plans to reduce his stake in the company by no more than 0.85% [6] - Zhanpeng Technology: Shareholders plan to collectively reduce their stake in the company by no more than 3.18% [6] - Qixia Construction: Shareholder Nanjing Gaoke plans to reduce its stake in the company by no more than 3% [6] Group 4 - Laisentongling: Shareholder Ningbo Ningju plans to reduce its stake in the company by no more than 1% [6] - Huapei Power: Plans to repurchase shares worth between 10 million to 20 million yuan [6] Group 5 - Maiwei Bio: Signed an exclusive licensing agreement with Kalexo, which will provide up to 1 billion USD in upfront and milestone payments [6] - Gongda High-Tech: Signed a strategic cooperation agreement with China Coal Mine Construction Group [6] - Changhua Group: Received a notice for targeted development from a domestic car manufacturer, with an expected total sales amount of approximately 280 million yuan over its lifecycle [6] Group 6 - Pingzhi Information: Pre-awarded a project for artificial intelligence computing power technology services worth approximately 170 million yuan [6] - Pinming Technology: Planning a major event that may lead to a change in company control, resulting in stock suspension [6] - Jinxiandai: Gold Modern convertible bonds will cease trading after the market closes on September 18 [6] Group 7 - Heng Rui Pharmaceutical: HRS-5635 injection has been included in the list of proposed breakthrough treatment varieties [6] - China Ping An: Long-term service plan for 2025 has completed stock purchases [6]